title: [What's new in pediatric nephrology?].
abstract: Advances in pediatric nephrology has been mainly characterized during the last years by a burst of knowledge in the area of genetic renal diseases: 1/almost complete understanding of Alport syndrome related to mutations of COL4A5 or COL4A3/A4 genes of collagene; 2/the mapping and cloning of the nephronophthisis gene which is deleted in 75% of cases; 3/the mapping and cloning of the cystinosis gene coding for a protein of the lysosomal membrane; 4/the mapping and cloning of the Finnish-type congenital nephrotic syndrome gene; 5/the linkage to the SNR 1 gene on chromosome 1 of a large number of familial corticoresistant nephrotic syndromes, and the disclosure of mutations of the WT1 gene in diffuse mesangial sclerosis and in Frazier syndrome. The understanding of Bartter syndrome has been also enlightened by the discovery of mutations in several ionic channels located in the distal tubule. It has been also shown that a corticoresistant nephrotic syndrome or a chronic tubular interstitial nephropathy are possible phenotypes for mitochondrial cytopathies. In the area of therapeutics, recombinant growth hormone was shown to improve statural growth of children with chronic renal failure; in addition, renal transplantation benefits from new immunosuppressants as tacrolimus and mycophenolate mofetil.
authors.affiliation: Inserm U 423, hôpital Necker-Enfants-malades, université René-Descartes, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Broyer
mesh_terms: D002648:Child; D002874:Chromosome Mapping; D003094:Collagen / Q000235:genetics; D006801:Humans; D007674:Kidney Diseases / Q000235:genetics*; D009154:Mutation; D009394:Nephritis, Hereditary / Q000235:genetics
chemical_list: D003094:Collagen